Trial Details
COMPLETEDBasic Information
| Clinical ID | c1403 |
|---|---|
| Identifier | NCT00303381 |
| Trial Title | Safety and Efficacy of Interferon-Beta-1a (Rebif) for Treating Subjects With Acute Symptoms of Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Interferon-beta-1a, 44 microgram|DRUG: Placebo|DRUG: Interferon-beta-1a, 66 microgram |
Participant Information
| Sponsor | EMD Serono |
|---|---|
| City | Munich |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-01 |
|---|---|
| Primary Completion Date | 2025-01-03 |
| Completion Date | 2025-01-03 |